Alunbrig Gets FDA Approval for Frontline ALK-Positive Lung Cancer Patients
FDA has approved Alunbrig or Brigatinib for first-line treatment of patients with ALK-positive metastatic non-small cell lung cancer, as detected by
U.S. FDA Gives Nod To Bristol-Myers Combo Therapy For Lung Cancer
Non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancer cases. Lung cancer patients in advanced stages of
FDA Approves Tabrecta, First Targeted Therapy for NSCLC
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other
Categories : Lung CancerLeave a comment
Lung Cancer Patients May Face Risk of Death from COVID-19
The continuous fear of COVID-19 is on the rise. With more and more people getting trapped in this pandemic, it